- Report
- November 2023
- 77 Pages
Germany
From €3137EUR$3,500USD£2,691GBP
- Report
- November 2023
- 70 Pages
France
From €3137EUR$3,500USD£2,691GBP
From €3137EUR$3,500USD£2,691GBP
- Report
- November 2024
- 88 Pages
India
From €3137EUR$3,500USD£2,691GBP
- Report
- August 2024
- 80 Pages
Saudi Arabia
From €3137EUR$3,500USD£2,691GBP
- Report
- April 2024
- 183 Pages
Global
From €4033EUR$4,500USD£3,460GBP
- Report
- October 2023
- 90 Pages
India
From €3137EUR$3,500USD£2,691GBP
- Report
- October 2023
- 73 Pages
Malaysia
From €3137EUR$3,500USD£2,691GBP
- Report
- May 2024
- 200 Pages
Global
From €3719EUR$4,150USD£3,191GBP
- Report
- March 2024
- 200 Pages
Global
From €3719EUR$4,150USD£3,191GBP
- Report
- March 2024
- 200 Pages
Global
From €3719EUR$4,150USD£3,191GBP
- Report
- March 2024
- 200 Pages
Global
From €3719EUR$4,150USD£3,191GBP
- Report
- January 2024
- 200 Pages
Global
From €3719EUR$4,150USD£3,191GBP
- Report
- January 2024
- 200 Pages
Global
From €3719EUR$4,150USD£3,191GBP
- Report
- June 2025
- 400 Pages
Global
From €4435EUR$4,949USD£3,805GBP
- Report
- September 2023
- 160 Pages
Global
From €3225EUR$3,599USD£2,767GBP
- Report
- June 2024
- 200 Pages
Global
From €7125EUR$7,950USD£6,112GBP
- Report
- February 2024
- 120 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- February 2024
- 71 Pages
Europe
From €4257EUR$4,750USD£3,652GBP
- Report
- February 2024
- 120 Pages
Global
From €4257EUR$4,750USD£3,652GBP

Macular Degeneration is a condition that affects the central part of the retina, known as the macula, which is responsible for sharp, central vision. It is the leading cause of vision loss in people over the age of 50. Optical treatments for Macular Degeneration include laser photocoagulation, photodynamic therapy, and anti-VEGF injections. Laser photocoagulation is used to reduce the risk of further vision loss by sealing off leaking blood vessels in the macula. Photodynamic therapy is used to reduce the growth of abnormal blood vessels in the macula. Anti-VEGF injections are used to reduce the growth of abnormal blood vessels and improve vision.
Companies in the Macular Degeneration market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more